Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed May 10, 2013 · 10-Q · 41 days after period end · 0001415889-13-000907
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $2.33M | $1.79M | $2.54M |
| Net Income | -$1.42M | -$4.43M | -$1.16M |
| EPS Diluted | $0.01 | -$0.05 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Mar 30, 2013 · filed May 10, 2013 · 41 d after period end
